- Professional gathering in the field of aesthetics on July 5^th -

- Highlighting case study of Humedix’s aesthetic products -

  ▲Invitation to Humedix’s HART Symposium for healthcare professionals

Humedix of Huons Group will host an academic gathering to showcase its product competitiveness.

Humedix Co., Ltd. (Humedix; CEO Kang Min-jong) announced Wednesday that it started recruiting participants for its HART Symposium, covering case study in aesthetic field, to be held on July 5 at Grand InterContinental Seoul Parnas.

The symposium will highlight the latest Humedix products to medical professionals. It will feature skin booster ‘Elravie Re2O’, based on acellular allogeneic dermis (hADM). Since Elravie Re2O’s domestic launch in November last year, Humedix has conducted various online and offline academic marketing activities and it is being used in more than 300 dermatology clinics nationwide to improve skin.

In November last year, Humedix signed a distribution agreement with L&C Bio Co., Ltd. (L&C Bio) and secured domestic rights to sell Elravie Re2O to dermatologists and clinics. Elravie Re2O features L&C Bio’s patented human tissue processing technology, also known as ‘Alloclean Technology’. It has improved safety and effectiveness by removing factors that induce cell and immune rejection responses while maintaining the tissue`s unique 3D structure.

Humedix will also introduce HA filler ‘Elravie Premier’, botulinum toxin ‘LIZTOX’, drug injection device ‘Dermashine Pro’, bio cosmeceutical ‘Cell exosome’, as well as a variety of aesthetic products at the symposium.

The symposium will gather 120 prominent healthcare professionals (HCP) from Korea and abroad to share aesthetic insights, academic knowledge and clinical know-how. The symposium will be chaired by Dr. Je-young Park from Oracle Skin Clinic and case presentations will be delivered by Dr. Eun Yeon Kim from Beauty Bar Plastic Surgery Clinic and Dr. Sang-yub Kim from JF Dermatology Clinic.

The official title of the symposium, HART, stands for ‘Humedix experts in Aesthetic Regeneration & Technology’. It symbolizes Humedix’s pursuit of aesthetic regeneration and expertise in advanced technology, while also embodying its commitment to leading the future value of the aesthetic medicine.

Humedix’s HART Symposium will be held at Orchid Ballroom at Grand InterContinental Seoul Parnas on July 5, where medical experts in the field of aesthetics will share their opinions on recent trends.

Humedix’s CEO Kang Min-jong said, “We hope that this HART symposium will be meaningful to all participants to showcase the competitiveness of our next-generation skin booster ‘Elravie Re2O’, provide practical assistance in the clinical setting and present new direction in the aesthetic field. We will continue to host academic symposiums in the future to share high-quality trends and clinical know-how with healthcare professionals.”